The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLS.L Regulatory News (SLS)

  • There is currently no data for SLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Standard Life UK Smaller Co Tst

8 Oct 2021 07:00

RNS Number : 4029O
Standard Life UK Small.Co's Tst PLC
08 October 2021
 

 

London, UK, 08 October 2021

 

Edison issues review on Standard Life UK Smaller Companies Trust (SLS)

Standard Life UK Smaller Companies Trust (SLS) has two managers, Harry Nimmo and Abby Glennie at abrdn (formerly Aberdeen Standard Investments); therefore, a succession plan is in place should Nimmo choose to retire. They are positive on the outlook for UK smaller-cap stocks, which is reflected in the trust's higher level of debt compared with an ungeared position 12 months ago. The managers are encouraged by SLS's very strong relative performance in recent months as investors have once again gravitated towards the quality, growth and momentum stocks that are favoured by its disciplined and repeatable investment process. This approach has proved successful over several market cycles; Nimmo and Glennie are essentially delivering 'what it says on the tin'.

 

SLS's shares are currently trading at a 7.5% discount to cum-income NAV, which compares with the 5.0% to 6.4% range of historical averages over the last one, three, five and 10 years.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Sarah Godfrey +44 (0)20 3681 2519 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADEXELLFFFA
Date   Source Headline
23rd Feb 202112:13 pmRNSNet Asset Value(s)
22nd Feb 20212:52 pmRNSGearing disclosure
22nd Feb 202112:08 pmRNSNet Asset Value(s)
19th Feb 20213:49 pmRNSNet Asset Value(s)
18th Feb 202111:00 amRNSNet Asset Value(s)
17th Feb 202111:57 amRNSNet Asset Value(s)
16th Feb 202111:26 amRNSNet Asset Value(s)
15th Feb 202112:31 pmRNSGearing Disclosures
15th Feb 202111:22 amRNSNet Asset Value(s)
12th Feb 202111:39 amRNSNet Asset Value(s)
11th Feb 20214:18 pmRNSPortfolio disclosure
11th Feb 202111:37 amRNSNet Asset Value(s)
10th Feb 202110:46 amRNSNet Asset Value(s)
9th Feb 202111:01 amRNSNet Asset Value(s)
8th Feb 202112:52 pmRNSGearing disclosure
8th Feb 202111:19 amRNSNet Asset Value(s)
5th Feb 202111:33 amRNSNet Asset Value(s)
4th Feb 20213:01 pmRNSMonth End Net Asset Value(s)
4th Feb 202111:53 amRNSNet Asset Value(s)
3rd Feb 202111:04 amRNSNet Asset Value(s)
2nd Feb 20211:33 pmRNSNet Asset Value(s)
1st Feb 20212:41 pmRNSGearing disclosure
1st Feb 202110:28 amRNSTotal Voting Rights
29th Jan 202112:32 pmRNSNet Asset Value(s)
28th Jan 202111:40 amRNSNet Asset Value(s)
27th Jan 20215:07 pmRNSTransaction in Own Shares
27th Jan 202111:44 amRNSNet Asset Value(s)
26th Jan 20211:00 pmRNSNet Asset Value(s)
25th Jan 20215:17 pmRNSTransaction in Own Shares
25th Jan 20212:33 pmRNSGearing disclosure
25th Jan 202112:33 pmRNSNet Asset Value(s)
22nd Jan 20215:03 pmRNSTransaction in Own Shares
22nd Jan 202111:42 amRNSNet Asset Value(s)
21st Jan 20215:01 pmRNSTransaction in Own Shares
21st Jan 202111:38 amRNSNet Asset Value(s)
20th Jan 20215:06 pmRNSTransaction in Own Shares
20th Jan 202111:00 amRNSNet Asset Value(s)
19th Jan 20215:00 pmRNSTransaction in Own Shares
19th Jan 202110:51 amRNSNet Asset Value(s)
19th Jan 20219:05 amRNSCompliance with Market Abuse Regulation
18th Jan 202112:57 pmRNSGearing disclosure
18th Jan 202112:38 pmRNSNet Asset Value(s)
15th Jan 202111:46 amRNSNet Asset Value(s)
14th Jan 202111:41 amRNSNet Asset Value(s)
14th Jan 202110:44 amRNSPortfolio disclosure
13th Jan 202111:47 amRNSNet Asset Value(s)
12th Jan 202111:09 amRNSNet Asset Value(s)
11th Jan 202111:50 amRNSGearing disclosure
11th Jan 202111:14 amRNSNet Asset Value(s)
8th Jan 202111:05 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.